ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PTN Palatin Technologies Inc New

2.08
0.08 (4.00%)
08 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Palatin Technologies Inc New AMEX:PTN AMEX Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.08 4.00% 2.08 2.14 2.00 2.04 152,795 01:00:00

Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024

09/02/2024 12:30pm

PR Newswire (US)


Palatin Technologies (AMEX:PTN)
Historical Stock Chart


From Feb 2024 to May 2024

Click Here for more Palatin Technologies Charts.

CRANBURY, N.J., Feb. 9, 2024 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its second quarter fiscal year 2024 operating results on Thursday, February 15, 2024, before the open of the U.S. financial markets.

Palatin Technologies, Inc.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on February 15, 2024, at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.

Schedule for the Operating Results Press Release, Conference Call / Audio Webcast


Q2 Fiscal Year 2024 Results Press Release

2/15/2024 at 7:30 a.m.ET



Q2 Fiscal Year 2024 Conference Call-Live

US Toll Free Dial-In Number:

International Dial-In Number:

Participant Access Code:

2/15/2024 at 11:00 a.m. ET

1-888-506-0062

1-973-528-0011

397299



Q2 Fiscal Year 2024 Conference Call-Replay 

US Toll Free Dial-In Number: 

International Dial-In Number:

Participant Access Code: 

2/15/2024-2/29/2024

1-877-481-4010

1-919-882-2331

49945

The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com or by clicking here.

About Palatin 
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/palatin-to-report-second-quarter-fiscal-year-2024-results-teleconference-and-webcast-to-be-held-on-february-15-2024-302058387.html

SOURCE Palatin Technologies, Inc.

Copyright 2024 PR Newswire

1 Year Palatin Technologies Chart

1 Year Palatin Technologies Chart

1 Month Palatin Technologies Chart

1 Month Palatin Technologies Chart

Your Recent History

Delayed Upgrade Clock